Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-24-052181
Filing Date
2024-04-25
Accepted
2024-04-25 20:43:12
Documents
1
Group Members
PETER KOLCHINSKYRA CAPITAL HEALTHCARE FUND, L.P.RAJEEV SHAH

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2412780d1_sc13g.htm SC 13G 92308
  Complete submission text file 0001104659-24-052181.txt   94291
Mailing Address 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116 617-778-2500
RA CAPITAL MANAGEMENT, L.P. (Filed by) CIK: 0001346824 (see all company filings)

EIN.: 830406777 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337
Protara Therapeutics, Inc. (Subject) CIK: 0001359931 (see all company filings)

EIN.: 204580525 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88372 | Film No.: 24878294
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)